Status:
RECRUITING
Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis
Lead Sponsor:
Al-Azhar University
Conditions:
Nocturnal Enuresis
Eligibility:
All Genders
7-14 years
Phase:
NA
Brief Summary
Nocturnal Enuresis (NE) is defined as the involuntary passage of urine during sleep past the age of usual control, which is considered a developmental age of 5 to 7 years. NE is a common problem that...
Eligibility Criteria
Inclusion Criteria:
- School age group (from 7 to 14 years)
- Primary monosymptomatic nocturnal enuresis
Exclusion Criteria:
Patients with one or more of the following will be excluded from the study.
- Diurnal enuresis
- Urinary tract infection within the preceding 3 months
- Diabetes mellitus
- History of renal disease, hypertension or genitourinary abnormality, neurological disease, or psychological disease.
- Post-micturition residual urine >1/3 expected bladder capacity.
- Each patient will be subjected to the following.
Key Trial Info
Start Date :
February 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 12 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06285006
Start Date
February 23 2024
End Date
May 12 2024
Last Update
April 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alazhar university
Asyut, Egypt, 11884